AURA

Aura Biosciences Inc

NASDAQ: AURA · HEALTHCARE · BIOTECHNOLOGY

$7.93

-2.50% today

Updated 2026-06-05

Market cap

$713.37M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-1.71

Dividend yield

—

52W range

$5 – $10

Volume

0.5M

Market cap

$713.37M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-1.71

Dividend yield

—

52W range

$5 – $10

Volume

0.5M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

6.0

Quality

3.0

Profitability

5.0

Valuation

C+

1/9

Piotroski F-Score

Weak

-2.7

Altman Z-Score

Distress

—

Industry rank

—

View all highly rated stocks (75+) →202 stocks currently score above 75

Price targets

Analyst target

$18.80

+137.07%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

1 Strong Buy5 Buy0 Hold0 Sell0 Strong Sell

Price chart

Stock snapshot

Strengths

+ Debt/equity 0.16x — low leverage

Risks

- Piotroski 1/9 — weak financial health

- Altman Z -2.71 — distress zone

- Thin margins at 0.00%

- Negative free cash flow $-30.00M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-58.76M	$-76.41M	$-86.92M	$-106.19M	$-33.69M
EPS	—	—	—	—	$-1.71
Free cash flow	$-55.70M	$-64.56M	$-81.06M	$-85.19M	$-30.00M
Profit margin	—	—	—	—	—

Recent insider activity

Date	Insider	Type	Shares	Price
2026-05-07	MATRIX, CAPITAL MANAGEMENT COMPANY, LP	Sale	6,922,870	$5.64
2026-04-16	KILROY, CONOR	Sale	11,738	$7.02
2026-03-02	PLAVSIC, MARK	Buy	112,661	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
AURA	$713.37M	22	4.3	3.0	5.0	6.0	—	Avoid
LLY	$948.95B	78	10.0	10.0	5.0	6.0	—	Strong Buy
JNJ	$536.54B	59	4.7	9.0	3.3	6.0	-71.41%	Buy
ABBV	$380.57B	63	4.0	8.0	4.0	5.0	-55.64%	Buy
UNH	$343.21B	54	5.3	5.5	4.7	5.5	-26.61%	Buy
MRK	$285.64B	50	3.3	8.0	2.7	5.0	-49.34%	Hold

Smart narrative

Aura Biosciences Inc trades at $7.93. Our Smart Value Score of 22/100 indicates the stock is weak. The company scores 1/9 on the Piotroski F-Score. With an Altman Z-Score of -2.71, it sits in the distress.

Frequently asked questions

What is Aura Biosciences Inc's stock price?

Aura Biosciences Inc (AURA) trades at $7.93.

Is Aura Biosciences Inc overvalued?

Aura Biosciences Inc carries a Smart Value Score of 22/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.

What is the price target of Aura Biosciences Inc (AURA)?

The 12-month analyst consensus target is $18.80, about 137.1% above the current $7.93. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.

Altman Z-Score?

Aura Biosciences Inc's Altman Z-Score is -2.71, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

www.aurabiosciences.com

Quick metrics

P/S ratio—

ROE-104.80%

Beta0.37

50D MA$7.25

200D MA$6.25

Shares out0.10B

Float0.09B

Short ratio—

Avg volume0.5M

Performance

1 week+0.00%

1 month-16.92%

3 months+11.62%

YTD+21.65%

1 year—

3 years—

5 years—

Compare

AURA vs LLY →AURA vs JNJ →AURA vs ABBV →Stock screener →